Freddie Mac’s big profit masked small earnings in its core business.
Strong Eylea sales sent Regeneron stock—and future expectations—ever higher.
Sprint’s fiscal first-quarter results showed better subscriber numbers and churn, but the company’s fundamental challenges remain.
Shire is venturing into bigger, riskier deal making with its $31 billion unsolicited bid to buy U.S. biotech Baxalta.
Scott Bessent will start his own hedge-fund firm, with a $2 billion investment from Soros Fund Management.
The market’s reaction to Chesapeake Energy’s dividend cut has provided a buying opportunity and potentially makes the company attractive to an acquirer.
A federal judge rejected a proposed $79 million class-action settlement between American Express and a group of merchants, citing a recent discovery that two opposing lawyers in the case had exchanged confidential documents.
Shire made an unsolicited $30.6 billion offer for rare-disease treatment maker Baxalta, becoming the latest deal-hungry company refusing to take “no” for an answer amid the current deal boom.
Etsy Inc., an online marketplace for handmade and vintage goods, saw its second-quarter loss sharply widened, as higher expenses hampered results.
Federal Reserve Board of Governors nominee Kathryn Dominguez said that if confirmed she plans to take an unpaid leave of absence from her job as a professor at the University of Michigan.